(Press-News.org) A combination of missed prevention opportunities and health inequalities can result in the early deaths of people living with epilepsy and intellectual disabilities, a study has shown.
Around 1.2million people in England have some form of intellectual disability, with epilepsy estimated to impact 20-25% of them – up to 300,000 people – compared to just 1% of the general population.
However, until now there has been no national-level population-based evidence on the risks and protective factors specifically contributing to epilepsy-related deaths in people with intellectual disability.
This new research aims to fill that gap, with its analysis of nearly 10,000 deaths between 2016 and 2021 constituting the largest global study examining epilepsy-related mortality in adults with intellectual disabilities and epilepsy.
It found epilepsy was the primary cause of death in just over 16% of those people, and that they died at a significantly younger average age – 56 compared to 62 – than those who had issues other than epilepsy listed as the primary cause of death in their health records.
The study particularly highlights significant disparities in epilepsy-related mortality based on ethnicity, with African and Asian individuals dying younger – at an average age of just 36 – than their White British counterparts.
All of this, the authors say, is despite the fact targeted interventions – including annual health checks, multidisciplinary care access, and specialist psychiatric and speech and language therapy support – do exist but are rarely administered in a uniform manner. The paper showcases these interventions as being effective at increasing a person’s length of life.
Writing in the Journal of Neurology, Neurosurgery, and Psychiatry, the study’s authors say poor quality of care, service gaps and the lack of annual health checks should be considered unacceptable in modern healthcare.
As such, they have called for a systemic service redesign to try and prevent avoidable epilepsy-related deaths among people with intellectual disabilities in the future.
The study was led by experts in epilepsy, intellectual disability and medical statistics from the University of Plymouth, the University of Exeter and Cornwall Partnership NHS Foundation Trust, working with colleagues in universities across the UK.
Professor Rohit Shankar MBE, Professor of Neuropsychiatry at the University of Plymouth and Director of its Cornwall Intellectual Disability Equitable Research (CIDER) unit, said: “Among neurological conditions, epilepsy is the biggest killer apart from stroke. Our study shows that among people who also have an intellectual disability, it poses a greater threat of them dying younger with those from ethnic minorities living in the UK being even more at risk. What is arguably even more shocking is that there are strategies including psychiatric support to speech and language therapy out there to help people. It is wholly unacceptable that these are not routinely and systematically used in a proactive manner everywhere in England, particularly when we’re talking about people who are extremely vulnerable and often have difficulties in communicating their needs or concerns. It is a situation that urgently needs addressing.”
Professor William Henley, Professor of Medical Statistics at the University of Exeter Medical School, said: “We hope our stark and shocking findings will act as a rallying cry to make a difference for families affected by epilepsy and learning disability. Our research paints a bleak picture – we owe it to these families to build on this to make a difference, to offer a brighter future.”
The research was based on data collected through the Learning from Lives and Deaths Review Programme (LeDeR), which focuses on learning from the lives and deaths of people with learning disabilities and autistic people, using reviews to improve local services.
Pauline Heslop, Emeritus Professor of Intellectual Disabilities Studies at the University of Bristol, was the Programme Manager for the LeDeR Programme for England from 2015-2021. She added: “I am pleased that the LeDeR data is still being used effectively to highlight areas of disparity in deaths of people with intellectual disability, and to indicate where policy and practice needs to be strengthened. It is of significant concern that epilepsy-related deaths are associated with a poorer quality of care and gaps in service provision when compared to non-epilepsy related deaths – issues which need addressing at individual and systemic levels.”
The study’s authors have been working for several years with charities and other healthcare organisations who support people affected by epilepsy and learning disabilities.
This has resulted in the development of dedicated programmes such as the Clive Treacey Safety Checklist (co-developed by NHS England Midlands, the University of Plymouth, Cornwall Partnership NHS Foundation Trust and the charity SUDEP Action) and the SUDEP and Seizure Safety checklist, which is highlighted in the study as a resource that should be used more widely in the future.
The Clive Treacey checklist was named in honour of a man who died aged 47 having been kept in a psychiatric unit without having his health needs fully addressed.
Clive’s sister, Elaine Clarke, said of the new findings: “It's deeply shocking to see that there are so many people with a learning disability who, just like my brother Clive, continue to die avoidable deaths because they do not receive the epilepsy care and treatment that they should. If these terrible statistics belonged to almost any other part of society there would be public outrage – but the harsh reality is that people like my brother Clive, are not valued or prioritised.”
The findings have also been welcomed by UK-based charities, who said the research reinforces their ongoing calls for a complete overhaul of NHS care for people with epilepsy and intellectual disabilities.
Jane Hanna OBE, Co-Founder and Director of Policy and Influencing of SUDEP Action, said: "The stark findings of this large study are welcomed as they reflect the experience of families of the significant gaps in basic care and communication over three decades since SUDEP Action was founded. Today there is a stark lottery between the local NHS areas that are working with the charity to adopt the free SUDEP and Seizure Safety Checklist and areas that are still operating in ignorance that epilepsy is a cliff-edge condition that requires advocacy and risk management."
Alison Fuller from Epilepsy Action said: "This research lays bare the shocking inequalities faced by people with epilepsy and a learning disability. It clearly shows that they are dying far too young and acts as a stark reminder that this group remains among the most at-risk group in our health system. Even more concerning is the finding that people from African and Asian backgrounds face an even greater risk of dying prematurely, exposing deep-rooted and persistent inequalities. These are preventable deaths! With annual health checks, access to the right professionals and truly joined up person centred care plans, lives can be saved, but too often support is either inconsistent or unavailable. The evidence is clear the NHS must act urgently to deliver proactive, coordinated, equitable care, so that everyone with epilepsy and a learning disability has the chance to live a longer, healthier life."
Kate Chate, Family Member Election Representative Co Chair for Learning Disability England, added: “It is so encouraging to see research being done into the causes of early and preventable deaths of people with learning disabilities. Knowing 'why' is surely the start of the road to prevention? This paper shows the very stark and alarming difference for people with Black, Afro Caribbean and Asian origins. And it reveals that input from psychiatrists and speech & language therapists is particularly important. As a family member this kind of research that brings data to advocate for better services for people with Learning Disabilities is more than just welcome, it is very gratefully applauded.”
END
Epilepsy can lead to earlier deaths in people with intellectual disabilities, study shows
A team of UK-based researchers say the statistics are the result of missed opportunities and health inequalities, while campaigners believe it should be a source of public outrage
2025-12-11
ELSE PRESS RELEASES FROM THIS DATE:
Global study suggests the underlying problems of ECT patients are often ignored
2025-12-11
A major international survey of people receiving electroconvulsive therapy (ECT) has found that most patients are not asked about the childhood adversities or recent life stressors that they believe caused their difficulties.
The survey findings, published in the International Journal of Mental Health Nursing, suggest that people are prescribed ECT, often against their will, without the underlying causes of their mental health problems being recognised and addressed by other therapeutic means.
The ...
Mapping ‘dark’ regions of the genome illuminates how cells respond to their environment
2025-12-10
Researchers at Duke University used CRISPR technologies to discover previously unannotated stretches of DNA in the ‘dark genome’ that are responsible for controlling how cells sense and respond to the mechanical properties of their local environment.
Understanding how these DNA sequences affect cellular identity and function could give researchers new therapeutic targets for illnesses that involve changes to mechanical properties of tissues, including fibrosis, cancer and stroke, as well as long-term issues such as neurodegeneration and even aging.
This work appears online on September 25 in the journal Science.
The ...
ECOG-ACRIN and Caris Life Sciences unveil first findings from a multi-year collaboration to advance AI-powered multimodal tools for breast cancer recurrence risk stratification
2025-12-10
Today at the San Antonio Breast Cancer Symposium (SABCS), researchers presented the initial findings from a major multi-year collaboration between the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) and Caris Life Sciences® (Caris) focused on transforming recurrence risk assessment in early-stage breast cancer through artificial intelligence (AI). The public-private partnership pairs ECOG-ACRIN’s extensive clinical trial expertise and biorepository resources with Caris’ comprehensive MI Cancer Seek® whole exome and whole transcriptome profiling, whole slide imaging, ...
Satellite data helps UNM researchers map massive rupture of 2025 Myanmar earthquake
2025-12-10
The March 28, 2025, Myanmar earthquake is giving scientists a rare look into how some of the world’s most dangerous fault systems behave, including California’s San Andreas Fault. Earthquakes are notoriously messy and complex, but this one struck along an unusually straight and geologically “mature” fault, creating near-ideal conditions for researchers to observe how the Earth releases energy during a major continental rupture.
An international team of researchers led by The University ...
Twisting Spins: Florida State University researchers explore chemical boundaries to create new magnetic material
2025-12-10
Florida State University researchers have created a new crystalline material with unusual magnetic patterns that could be used for breakthroughs in data storage and quantum technologies.
In a study published in the Journal of the American Chemical Society, the research team showed that when two materials with neighboring chemical compositions but different structure types are combined, they can form a new material that exhibits a third structure type with highly unusual magnetic properties.
Atoms in magnetic materials act as extremely small magnets, ...
Mayo Clinic researchers find new hope for toughest myeloma through off-the-shelf immunotherapy
2025-12-10
ROCHESTER, Minn. — A new Mayo Clinic study published in the New England Journal of Medicine has uncovered that an off-the-shelf, dual-antibody therapy can generate deep and durable responses in extramedullary multiple myeloma — one of the most aggressive and treatment-resistant forms of the disease.
"We are seeing powerful responses in a disease that historically has resisted every therapy," says Shaji Kumar, M.D., a Mayo Clinic Comprehensive Cancer Center hematologist and senior author of the study. "By recruiting T cells ...
Cell-free DNA Could Detect Adverse Events from Immunotherapy
2025-12-10
A noninvasive blood test to detect genetic material shed by tumors may help clinicians identify adverse events related to treatment with immune checkpoint inhibitor drugs, investigators at the Johns Hopkins Kimmel Cancer Center have found.
In a Dec. 11 letter to the editor of the New England Journal of Medicine, the researchers described how they measured cell-free DNA to identify tissue damage to nine organs in a study involving 14 patients with solid tumors who received immune checkpoint inhibitor therapy, a treatment that helps boost the immune system’s ability to attack cancer. The test determined that the six patients in the cohort who had immune-related adverse events ...
American College of Cardiology announces Fuster Prevention Forum
2025-12-10
The American College of Cardiology is launching an early cardiovascular disease prevention education program to honor the contributions of Valentin Fuster, MD, PhD, MACC, and his lifelong commitment to establishing a culture of prevention in children. The Fuster Prevention Forum is an in-person educational course that will teach clinicians effective ways to educate children, parents and educators in their communities on nutrition, physical activity and emotional well-being.
“Valentin Fuster has a legacy of promoting heart healthy behaviors early ...
AAN issues new guideline for the management of functional seizures
2025-12-10
EMBARGOED FOR RELEASE UNTIL 4:00 P.M. ET, WEDNESDAY, DECEMBER 10, 2025
Highlights:
A new guideline by the American Academy of Neurology says psychological interventions are possibly effective in helping people achieve freedom from functional seizures.
Functional seizures, previously known as psychogenic nonepileptic seizures or non-epileptic attack disorder, can look or feel like seizures from epilepsy or fainting, but they have their own typical features.
The guideline says appropriate treatment may decrease the frequency of functional seizures, decrease anxiety and improve quality of life.
The guideline recommends that antiseizure ...
Could GLP-1 drugs affect risk of epilepsy for people with diabetes?
2025-12-10
EMBARGOED FOR RELEASE UNTIL 4:00 P.M. ET, WEDNESDAY, DECEMBER 10, 2025
Highlights:
GLP-1 drugs show a potential link to reduced epilepsy risk in people with type 2 diabetes.
People taking GLP-1 drugs were 16% less likely to develop epilepsy than those on DPP-4 inhibitors.
Semaglutide showed the strongest association with lower epilepsy risk among the GLP-1 drugs studied.
The study is preliminary and does not prove causation; randomized, controlled trials are needed to confirm these findings.
The drug tirzepatide was not included as it was introduced during the study period.
MINNEAPOLIS — A preliminary study of people with diabetes suggests ...
LAST 30 PRESS RELEASES:
Decoupling the HOR enhancement on PtRu: Dynamically matching interfacial water to reaction coordinates
Sulfur isn’t poisonous when it synergistically acts with phosphine in olefins hydroformylation
URI researchers uncover molecular mechanisms behind speciation in corals
Chitin based carbon aerogel offers a cleaner way to store thermal energy
Tracing hidden sources of nitrate pollution in rapidly changing rural urban landscapes
Viruses on plastic pollution may quietly accelerate the spread of antibiotic resistance
Three UH Rainbow Babies & Children’s faculty elected to prestigious American Pediatric Society
Tunnel resilience models unveiled to aid post-earthquake recovery
Satellite communication systems: the future of 5G/6G connectivity
Space computing power networks: a new frontier for satellite technologies
Experiments advance potential of protein that makes hydrogen sulfide as a therapeutic target for Alzheimer’s disease
Examining private equity’s role in fertility care
Current Molecular Pharmacology achieves a landmark: real-time CiteScore advances to 7.2
Skeletal muscle epigenetic clocks developed using postmortem tissue from an Asian population
Estimating unemployment rates with social media data
Climate policies can backfire by eroding “green” values, study finds
Too much screen time too soon? A*STAR study links infant screen exposure to brain changes and teen anxiety
Global psychiatry mourns Professor Dan Stein, visionary who transformed mental health science across Africa and beyond
KIST develops eco-friendly palladium recovery technology to safeguard resource security
Statins significantly reduce mortality risk for adults with diabetes, regardless of cardiovascular risk
Brain immune cells may drive more damage in females than males with Alzheimer’s
Evidence-based recommendations empower clinicians to manage epilepsy in pregnancy
Fungus turns bark beetles’ defenses against them
There are new antivirals being tested for herpesviruses. Scientists now know how they work
CDI scientist, colleagues author review of global burden of fungus Candida auris
How does stroke influence speech comprehension?
B cells transiently unlock their plasticity, risking lymphoma development
Advanced AI dodel predicts spoken language outcomes in deaf children after cochlear implants
Multimodal imaging-based cerebral blood flow prediction model development in simulated microgravity
Accelerated streaming subgraph matching framework is faster, more robust, and scalable
[Press-News.org] Epilepsy can lead to earlier deaths in people with intellectual disabilities, study showsA team of UK-based researchers say the statistics are the result of missed opportunities and health inequalities, while campaigners believe it should be a source of public outrage